P/S ratio for Reata Pharmaceuticals (RETA)

P/S ratio on November 17, 2023 (TTM) : 280

According to Reata Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 75.2. At the end of 2023 the company had a P/S ratio of 163.

P/S ratio history for Reata Pharmaceuticals from 2016 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	163	-74.04%
2022	628	652.15%
2021	83.5	-83.13%
2020	495	93.42%
2019	256	722.34%
2018	31.1	102.24%
2017	15.4	57.35%
2016	9.78

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
ORIC Pharmaceuticals ORIC	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions